Positive and negative symptoms during neuroleptic treatment.
Kramer
M S
MS
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000139:chemically induced / Q000175:diagnosis; D003937:Diagnosis, Differential; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D010276:Parasympatholytics